























![]()
Bionano Genomics, Inc. (BNGO) Q1 2026 Earnings Call May 13, 2026 4:30 PM EDT
Company Participants
Albert Luderer - Chairman & Interim CEO
Mark Adamchak - VP of Accounting, Principal Accounting Officer & Controller
Conference Call Participants
Webb Campbell - Gilmartin Group LLC
Yi Chen - H.C. Wainwright & Co, LLC, Research Division
Presentation
Operator
Good day, and welcome to the Bionano First Quarter 2026 Earnings Conference Call. Today's conference is being recorded.
At this time, I would like to turn the conference over to Webb Campbell from Gilmartin Group. Please go ahead.
Webb Campbell
Gilmartin Group LLC
Thank you, Liz, and good afternoon, everyone. Welcome to the Bionano First Quarter 2026 Financial Results Conference Call. On the call today is Dr. Al Luderer, Chairman and Interim CEO of Bionano; and Mark Adamchak, Bionano's Vice President of Accounting and Principal Accounting Officer. After market closed today, Bionano issued a press release announcing its financial results for the first quarter 2026. A copy of the release can be found on the Investor Relations page of the company's website.
Certain statements made during this conference call may be forward-looking statements. Actual results may differ materially from such statements due to several factors and risks, some of which are identified in Bionano's press release and Bionano's reports filed with the SEC. These forward-looking statements are based on information available to Bionano today, May 13, 2026, and the company assumes no obligation to update statements as circumstances change.
During our call, we may refer to certain adjusted financial measures, which we believe provide useful information for investors. Reconciliations of these measures to GAAP can be found in our press release and slide deck. An audio recording and webcast replay for today's conference call will also be available online on the Investor Relations page of the company's website.
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。